drugset / Trial / NCT06354127
DWP450 for Treating Moderate to Severe Glabellar Lines
RandomizedParallel-groupDouble-blindTreatment
Summary
A multi-center, randomized, double-blind, positive drug-controlled clinical study to evaluate the safety and efficacy of Botulinum Toxin Type A for Injection in the treatment of moderate to severe glabellar lines
Timeline
- Start
- 2020-08-12
- Primary completion
- 2020-11-24
- Completion
- 2021-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | — | Other |
| Subject | PrabotulinumtoxinA | Protein / enzyme biologic | — | Other |
Indications
No indication recorded.